 WATERTOWN, Mass., Sept. 07, 2021 GLOBE NEWSWIRE -- Kala Pharmaceuticals, Inc. NASDAQ:KALA, a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that management will participate in the following virtual healthcare investor conferences in September 2021: 